ArticleScientific data2025
Computed ECD spectral data for over 10,000 chiral organic small molecules.
Article in Scientific data, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Structural determination of natural products at speeds and scale of high-throughput screening.Natural product reports · 2026Review
- Computed ECD spectral data for over 10,000 chiral organic small molecules.Scientific data · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Determining the absolute configuration of chiral molecules is of fundamental importance in the fields of natural products chemistry, asymmetric catalysis, and pharmaceutical development. A widely adopted approach involves the comparison of experimental and theoretical electronic circular dichroism (ECD) spectra, which has proven to be a reliable method for absolute configuration assignment. However, the generation of theoretical ECD spectra via time-dependent density functional theory (TD-DFT) remains the rate-limiting step in this workflow, making its acceleration both essential and challenging. Although recent advances in deep learning offer promising strategies for establishing structure-spectrum relationships and expediting theoretical spectrum prediction, the lack of standardized and comprehensive ECD spectral datasets continues to hinder progress. This study presents the Chiral Molecular Circular Dichroism Spectral (CMCDS) dataset, a systematically structural benchmark dataset that addresses the fragmentation of existing ECD data. Characterized by high standardization, scalability, and broad molecular diversity, CMCDS facilitates deep learning applications in ECD analysis and fosters data-driven discovery of chiral molecules.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.